Sequent Medical: Terumo : Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Embolization Device -Accelerating Growth in Neurovascular Treatment-

(4-traders.com) June 14, 2016 Terumo Corporation (Headquarters: Tokyo, Japan; President and CEO: Yutaro Shintaku) announced today that it has entered into an agreement (hereafter 'the acquisition') to purchase Sequent Medical, Inc. (California, United States; hereafter 'Sequent'), a privately-held firm developing a new...http://www.4-traders.com/TERUMO-CORP-6491240/news/Terumo-Acquires-Sequent-Medical-U-S-based-Developer-of-New-Aneurysm-Embolization-Device-Acceler-22518112/